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Why is it needed to develop system biology initiatives such as ENCODE on non-model organisms?The next generation genomics era includes
non-model organisms
Genetics, and now genomics, applied to model organ-
isms continues to be hugely successful at identifying and
characterizing DNA elements and mechanisms involved
in major biological processes, such as the regulation of
development, cell cycle and cell signaling. However, the
number of organisms that are supported by large re-
search communities applying genetic approaches is lim-
ited. Organisms such as Escherichia coli, Saccharomyces
cerevisiae, Arabidopsis thaliana, Caenorhabditis elegans,
Drosophila melanogaster, Danio rerio or Mus musculus
are elected as “super model organisms” mainly based on
their important yet curious biological attributes and
many technical advantages. Drosophila emerged as the
premier study system for genetics because of naturally
occurring visible mutants, which led to the discovery of
chromosomal heredity, while Caenorhabditis was se-
lected as the main organism for studies of cell differenti-
ation and development because its cell lineage is nearly
invariant from egg to adult. All are ideal targets for gen-
etics as they are easily reared or cultivated in the lab in
order to systematically generate the necessary mutants
or genetic crosses. Model organisms in genetics share
common traits including short life cycles and a high fer-
tility rate. They are robust cosmopolitan resources of
laboratory experiments.
The trade-off to using model organisms is that they
are often not “typical” and do not reflect the biology of
their close relatives or even the wide diversity of living
mechanisms. They also display only a fraction of the traits
found in the biosphere, often limited to observations made* Correspondence: denis.tagu@rennes.inra.fr
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reproduction in any medium, provided the orin the laboratory. Yeast, for example, does not form multi-
cellular hyphae and A. thaliana has no known root symbi-
oses. C. elegans and D. melanogaster are not pathogens or
pests and the zebra fish is certainly not adapted to living in
marine environments. Similarly, rats and mice, typically
used as models in biomedical research, are nocturnal not
diurnal. Even commonly used human cell lines, such as
HeLa cells show strong rDNA rearrangements [1,2]. It is
perhaps no surprise that over 50% of many genomes of
model species are still without experimentally determined
functional annotations when many traits are conditionally
expressed in varying and natural environments. In addition
to the lack of phenotypic representation in model
organisms, it is worth noting that many species that ei-
ther participate in anchoring ecosystems (e.g. keystone
species) or are responsible for many health, agronomi-
cal and environmental challenges (e.g. human and
animal disease causing agents, plant pests, invasive
species) are not model organisms.
Fortunately, the recent advent of Next Generation Se-
quencing (NGS) coupled with other high-throughput
and high-definition analyses of the cellular organic mole-
cules (compound screening, mass spectrometry) provide
the opportunity to rapidly generate genomic, transcrip-
tomic, proteomic and metabolomic resources for po-
tentially any organism and their populations. More
than 1,300 eukaryotic genome sequences are archived
in NCBI as of April 2014 (ftp://ftp.ncbi.nlm.nih.gov/
genomes/GENOME_REPORTS/). Clearly, the number
of genome data submissions has steadily risen over re-
cent years, notably between 2009 and 2010 (Figure 1).
This trend will persist and accelerate as the cost of se-
quencing continues to plummet. However, many gen-
ome sequencing projects concern species that are
closely related to already well-characterized model or-
ganisms; of 2,401 listed project at NCBI, only 991d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Histogram of released genome sequences in NCBI per
year. A steady increase can be observed after 2003, with a brutal
acceleration after 2010 (data from “ftp://ftp.ncbi.nlm.nih.gov/
genomes/GENOME_REPORTS/” downloaded November 2013).
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thereby illustrating a focus on sequencing genomes
from related strains or populations of model species,
which benefit from mature genome structure annota-
tions and a wealth of other functional genetic informa-
tion generated by closely-related model organisms.
Nonetheless, research groups studying alternative spe-
cies, (which are evolutionarily distant from traditional
models and usually not amenable to forward genetics),
can contribute much new knowledge and important
discoveries in this “omics” era, by exploring biodiver-
sity at the molecular level and by describing the natural
history of genomes. Several consortia are organized to
sequence large swaths of the tree of life (e.g. 10,000
thousands vertebrate genomes, 5,000 arthropod ge-
nomes) [3,4], promising a greater diversity of se-
quenced genomes within the coming years.
However, this fresh stream of data is too often har-
vested ad minima. Genome sequences are frequently
produced solely to obtain gene annotations that are
borrowed from functional ontologies for genes in model
species. Such borrowed annotations are generally achieved
via combining computational gene prediction (e.g. Open
Reading Frame (ORF) predictions) with sequence align-
ments and homology comparisons to these well-annotated
model organism genomes, including that of humans. Too
little investment is presently given to experimentally valid-
ate the evolutionary functional conservation of these ho-
mologues or to investigate the diversity of genes that are
lineage-specific and whose functions are best described in
the context of the ecology and evolutionary history of thesequenced organism. Yet just as functional genome
annotations in model species are made reliable by
comprehensive and systematic investigations, a similar
community-level pursuit of a comprehensive and struc-
tured comparative genomics knowledge-base is required to
understand the biodiversity of genomes.
Non-model organism genomes beyond genes
The main goal of this paper is to collect thoughts and
discussions to initiate community-based genomic data
integrations for non-model organisms. We especially
wish to discuss (i) how to share genomic knowledge
obtained via different technologies, and provide useful
comparisons metrics for scientific discoveries linking
genome structures to biological functions, (ii) guide-
lines for the different phases or steps of these projects
(see below), and (iii) types of data needed for additional
annotations of genomes that may reach beyond indi-
vidual labs to generate otherwise difficult comparative
and important biological findings, derived from a col-
lective effort.
The rationale for these thoughts is based on the recent
history of genome sequencing projects and the fact that
functional annotation of DNA elements, especially tar-
gets of natural selection, is needed for non-model organ-
isms. It is becoming clear that valuable gene-by-gene
approaches to molecular biology under uniform environ-
mental conditions are not ideal when the scientific goal is
to elucidate whole biochemical pathways, or emergent fea-
tures of cellular and organismal biology that are expressed
and have evolved under varying environmental conditions.
Molecules present in cells, tissues and organs function
within integrated systems [5]. It is the multiplicity of
regulatory interactions within and between units – whether
among cells or individuals responding to environmental
conditions – that gives rise to complexities of biological or-
ganizations. The genetic component of the phenotypes of
interest depends on variations across many domains be-
yond the coding regions of the genome. Regulatory ele-
ments, chromosome and chromatin architecture, repeat
sequences mobilization, all have roles to play in building
morphological and behavioral traits. In most assemblies for
which we have a high quality annotation, exons represent
only a fraction of the genome (in Drosophila, 25.7% of the
169 Mb of sequenced genome is comprised of exons; com-
pare to 1.5% in the Human genome). This huge amount of
unannotated sequence data potentially harbors key ele-
ments of the genetic underpinnings of phenotypes, if only
their full functional repertoires were known. The ENCODE
(ENCyclopedia Of DNA Elements) research programme,
led by the National Human Genome Research Institute, ex-
plored the definition of “gene” in the light of functional
genomics and systems biology data sets [6,7]. The notional
definitions of “gene” reasonably vary between disciplines,
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tions. Traditional genetic approaches identify gene products
that are necessary and sufficient for an expressed pheno-
type. Yet in terms of “function”, the definition of gene tran-
scends its capacity to produce a transcript, or a protein.
Additional knowledge of genomic variation segregating
within and among populations with known ecologies, of
regulatory elements and the networks that govern gene ex-
pressions under both neutral and adaptive evolution reveals
the importance of alternative signatures to the functional
attributes of DNA elements. Genome plasticity observed in
animals and plants is likely to reveal new functional ele-
ments that are necessary for the expression of fitness re-
lated traits. Indeed this path to discovery may be amplified
when studying the genomes of populations and the organis-
mal molecular responses to their environmental challenges.
In the early 2000s, communities working on model or-
ganisms anticipated the tremendous power of nucleic
acid sequencing and protein characterization; these com-
munities aimed to catalog all the interactions through
which DNA elements influence cellular and organismal
biology. ENCODE [6,7] is one consortium-led initiative
that was launched soon after the publications of the hu-
man genome, in order to identify (annotate) the entire
DNA landscape of functional elements in this genome.
This was (still is) a progressive stage that follows other
post-genome sequencing initiatives such as the HapMap
consortium project describing human genome diversity
[8] - further supplemented by the 1,000 genomes Project
[9] - or the Human Microbiome Project [10] that com-
piles microbe interactions in either healthy or diseased
humans. Of course there are recent phylogenomics ini-
tiatives too describing the evolutionary history of the
human genome by comparing it to other primates,
mammalians or other species genomes. ENCODE is a
top-down initiative, with open calls for proposals by bio-
medical research groups that conceived of novel ap-
proaches to reach the project’s goals. ModENCODE was
developed as pilot experiments using C. elegans [11] and
D. melanogaster [12] to set up tools and to check for the
feasibility of the ENCODE programme, much as the
shot-gun D. melanogaster genome project [13] was a
pilot experiment for the shot-gun human genome
[14,15]. Now that the ENCODE initiative enters into
its second phase, integrations between HapMap, HMP
and ENCODE should give positive and added value to
post-genome sequencing projects, a kind of 3.0 step of
genomics (1.0 being the genome project, 2.0 the indi-
vidual ENCODE, HapMap, HMP projects).
For these reasons, ecology, evolutionary biology or
diversity in its outputs were not considered parts of the
modENCODE and ENCODE projects, which were mostly
based on developmental and cell biology as a basis for
addressing biomedical issues. Most annotations of thefunctional DNA elements revealed by ENCODE follows an
ontogenic vocabulary adapted to biomedical research, al-
though the notion of functional DNA in ENCODE has
been long debated [16,17]. However this so-called ‘Gene
Ontology’ (GO) does not completely encapsulate ecological
traits for describing biological processes, cell components
and molecular functions. This is a critical discrepancy of
the GO since finally, even for model organisms with well-
known genetics techniques and many mutants, the function
of many predicted genes is still unknown. For example,
7,574 D. melanogaster genes out of its total set of 16,656
genes (Release 5.54) are still “Computed Genes” with no
observed phenotypes. Initial genomics investigations of
orthologous genes in ecological model species are
pointing to many “Computed Genes” being expressed
under narrowly defined ecological conditions that are
not experienced in laboratory settings. This observa-
tion has consequences for the annotation of sequenced
genomes of non-model organisms, since their annota-
tion is mainly based on orthology with genes from
model organisms. For example, in the sequencing pro-
ject of the Monarch Butterfly (Danaus plexippus), a set
of 16,866 predicted genes is presented [18]. Of these,
roughly 1,000 gene annotations are manually scruti-
nized. Those validated genes are chosen based on a
priori expectations that they have central roles in the
butterfly’s migration. The authors supplemented their ana-
lysis with one type of regulatory mechanism (microRNA),
hinting that there are more discoveries to be made. Such a
fascinating investigation would greatly benefit from re-
sources to facilitate a more complete annotation of genes
and regulatory elements linked to migration. And in turn, a
knowledge-base that included annotations made in light of
the different ecological conditions and behaviors experi-
enced by non-model organisms (such as migration) will
help improve gene annotation of other non-model and
model species alike.
The case for systems biology initiatives on
non-model organisms
Large consortia projects often face many criticisms
[19,20]. For example, although ENCODE consortia were
able to deliver several useful achievements, perhaps the
focus should have been to promote the resource as
much as the findings. The integration of different assays
from molecular biology conducted with uniform proto-
cols on a controlled set of samples made it possible to
develop several tiers of genetic and epigenetic information
in the same systems. Similar utility has been achieved by
the RoadMap Epigenome Project, the BluePrint Epigenome
Project, and others. Many DNA elements of various types
have been mapped and annotated, with the objective to
establish interactions [12]. Already, discoveries are made
from this data integration of the experimentally derived
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CODE encode projects. In Drosophila modENCODE for
example, a class of DNA elements termed HOT regions for
High Occupancy Targets is better understood [21]. These
elements were described by modENCODE as regions in
the genome where a large number of different Transcrip-
tion Factors (TF) co-localize [12,22]. Thanks to the se-
quence motif signature of these HOT regions, further work
has independently demonstrated that they are regulated by
a single TF – crucial for the maternal to zygotic transcrip-
tion – and that HOT regions define a specific class of func-
tional enhancers [23].
ENCODE-like annotations are now a valuable inte-
grated resource used by many to advance their research
in model organisms. We argue that the next step is to
understand how the genetic system reacts in its full
natural context: when the developing organism is sub-
ject to all the challenges of, and interactions with, its
ecosystem. Thus, it becomes important to promote
data-driven modeling of all these environmentally
conditioned assays through ENCODE-like initiatives
for non-model-organisms, having knowledge of their
ecology. We refer to this approach as neoENCODE:
the functional annotation of genomes applied toFigure 2 A proposal of neoENCODE organization. A. The neoENCODE f
organizing genome-sequencing consortia. It will act at the level of annotat
for many genome projects. B. In order to give the neoENCODE framework
communities involved could chair this initiative. They could organize regula
component of this framework: the working groups. Each of this group cou
Some areas where they could be involved are highlighted on this figure. T
procedures, but also, ensure that those procedures are applicable to the peemerging and non-model organisms, which are typic-
ally not amenable to large-scale forward genetics. And,
just as the “one gene” approach is insufficient to inves-
tigate genome-wide transcriptional control, the “one
organism” approach also has its limitations. Sequen-
cing and imaging technologies can be used to identify
key players in the establishment of phenotypic traits
that govern inter-species relationships and give rise to
local and global ecologies. We propose that investiga-
tions in these and related areas are well-positioned to
transform our understanding of both organismal and
population biology by providing much-needed context.
To clarify, the proposed neoENCODE (Figure 2) has a
different structure and possibly a different mission to
modENCODE and ENCODE: neoENCODE is proposed
to be a bottom-up strategy (see below) because the com-
munities involved define their own needs and require-
ments, which are adapted to the size of the community and
biological specificities of the species of interest. Funding
support for these diverse neoENCODE initiatives will also
differ for each community. Yet the common thread that
links the activities of these communities into a neoEN-
CODE research programme is a shared road-map and a
shared knowledge-base infrastructure for integrating theramework will not take part in electing neo-model species nor in
ion and phenotypic association as a common integrative framework
more substance, a council of representatives from the different
r open meetings and hear the reports from the other structuring
ld work on experimental and analytical aspects of the project.
heir main task will be to create common guidelines for established
culiarities of each neo-model species.
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We can anticipate that some communities are sufficiently
well mobilized to begin this data integration sooner than
others, for example, those studying a first wave of ecological
and evolutionary genomics neo-model species, such as the
honey bee, Daphnia, aphid or the sea-urchin to name only
a few. neoENCODEs have the flexibility to be structured at
different levels: to accomplish large and ambitious projects,
planned across the timescale of a decade, or to realize
smaller and targeted projects addressing specific questions.
This federated and flexible approach at filling the current
knowledge gap on the diversity and function of genome
structures in light of ecology and evolution benefits
from lessons learned from over 10 years of community-
coordinated genomics research, which values bold
objectives and relies on interdisciplinary teamwork to ac-
complish them. A distinguishing feature of neoENCODE is
how, with the right strategic investments that expand exist-
ing database and information sharing infrastructure, its
organization is permitted to evolve with the number
neoENCODEs and the scale of their projects. As described
below, we need road maps and exchanges between neo-
ENCODEs communities to improve each of the individual
neoENCODE projects.
Another distinguishing feature of neoENCODE is the
point at which a project is completed, or the results deemed
to be comprehensive. ENCODE and modENCODE had/
have the ambition to screen a number of organs, tissues,
cells and biotic and abiotic challenges, mainly in laboratory
conditions, for empowering biomedical research. By con-
trast, NeoENCODE will endeavor to largely replicate many
ecological conditions across a wide array of non-model spe-
cies either under controlled conditions or directly from nat-
ural populations. Therefore neoENCODE will strengthen
environmental research knowledge on the environmental
associations with gene functions and phenotypes, including
disease.
In short, we propose herein a discussion on the appli-
cation of such an integrative approach using functional
genomics and post-genome sequencing data from non-
model organisms. This refers to ENCODE and modEN-
CODE initiatives but with a different perspective. Our
proposed initiative is not to create a new consortium,
structured and piloted by a coordinating group: this ap-
proach applies more to several bottom-up initiatives that
several communities might adopt, adapt and organize as
they wish, independently from one to another. With
moderate size of consortium – that self organizes - this
should limit the management difficulties and favor posi-
tive collaborative actions. However, meetings (such as
workshops, summer-schools) between those different fo-
cused initiatives could be efficient to share expertise and
best practices. Effectively, we thus do not propose any
cues for putative funding or sharing efforts (such as onbioinformatics) since each community could organize it
depending on its own objectives and contexts. But we
defend the idea that independent bottom-up neoEN-
CODE initiatives requires sharing common goals, prac-
tices and knowledge. Road maps are thus necessary to
the set up and are described below.Technical considerations for neoENCODE initiatives
The second part of this paper proposes (but does not
impose) road maps to help communities to consider the
added values of genomic data integration developed on
non-model organisms. If ENCODE is a map of data re-
sources (as suggested by Eddie [17] and we agree with
this suggestion), then neoENCODE will also consist of
maps, as global descriptions of elements positioned on
the genome that might interact in a cell. We propose a
common view for integration of genomic data at several
levels that can also be used to design new projects. These
different integration levels could concern expressed DNA
elements, as well as tissue organization, time-scaled and de-
velopmental processes, as well as inter-individual compa-
risons and inter-species comparisons, given the high
ecological and evolutionary knowledge of the species of
interest.
Technically, working with non-model organisms means
there is limited access to high-throughput functional assays.
Thus, the most effective approach for deciphering genom-
ics mechanisms from non-model organisms is to integrate
comparative data providing annotations of DNA, RNA,
and protein features. From a reference genome, thanks
to the work of several consortia, a clearer picture of
the gene structures, numbers, regulation and gene
orthologs emerges that are expected to be found across
phylogenetic distances from congenerics to organism
representing different phyla. It is easy to anticipate that
soon, the mapping of chromatin states, RNA, protein
and metabolite content (epigenetics, transcriptional,
post-transcriptional…) will be possible for a wide var-
iety of tissues and conditions for many, or even most
organisms. We argue that the most important contri-
bution of consortium scale biology, particularly of the
ENCODE Consortium, has been the establishment of
uniform data quality standards and assay conditions,
which have rendered thousands of experiments directly
comparable in several systems. We thus have the opportun-
ity here to rally such projects through a proposition of
guidelines for data generation and data exchange. This
again can be done utilizing some of the ENCODE consortia
principles [24].
Before going into a more detailed presentation of a pu-
tative road-map for neoENCODE, we propose to keep in
mind four technical differences between a neoENCODE
initiative and the now-concluded modENCODE projects:
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scientific community will be much smaller than the
communities working on model systems or human.
This means that it will be difficult to be as
comprehensive as modENCODE or ENCODE;
we can predict that the efficiency of a neoENCODE
initiative will be strengthened when the dedicated
community focuses on specific traits that each
non-model species will make particularly accessible
and amenable for study.
– It is probable that no cell lines will be available for
most of the non-model species. This will complicate
the interpretation of data sets. However, it can
actually provide added value if key tissues, organ
systems and conditions are targeted at the beginning
of the project to, again, focus on specific biological
processes.
– As discussed above, high throughput functional
assays are not systematically available for non-model
organisms. The knowledge provided by a neoENCODE
initiative will provide a roadmap for these, and will
generate the toolset needed for other studies in
ecological genomics. This points toward an economic
argument for funding such a project at this time,
during the emergence of this exciting
new field [25] we have the opportunity to establish
publically available biochemical and analytical
toolsets that will be useful to many researches
around the world.
– One of the main added values to genome studies is
the access to natural populations, that is often
covered by population geneticists. Including DNA
polymorphism diversity within the neoENCODE
projects can strengthen both the upstream steps
(including individual variation as a sample to
produce sequencing data) and downstream steps
(using natural variants as a source of functional
assays/validation) (see for technique: [26]). This is
what is occurring for Homo sapiens as ENCODE
data is integrated with the HapMap [27] and other
population-genetics resources.
A roadmap proposal for neoENCODE project
We think it is time to rally the different communities
and call to genomicists, biologists and computational
scientists. All those who are interested in understanding
how genomes interface with the natural world need to
join forces on a neoENCODE project. Genomic projects
in model organisms are well advanced and we can refer
to 4 main phases that described this genome projects
(Figure 2A):
Phase 1: draft genome (consortia for C. elegans, D.
melanogaster, H. sapiens, M musculus) that involvedthe choice of models as technical roadmaps of
feasibility.
Phase 2: finished genome assemblies and annotations,
Phase 3: annotation of DNA elements (pilot ENCODE,
modENCODE, ENCODE, mouseENCODE),
Phase 4: phenotypic annotation of the genomes
especially in Human with the use of population data for
GWAS studies, focus on medical trait.
The road-map we propose for neoENCODE integrates
this historical knowledge and tries to adapt it to the intrica-
cies of these future projects (see above). However, given the
million of species present on earth, how can neoENCODE
strategies be realistic and scale? Below are listed a series of
steps we think will be crucial to consider:
Learn from and integrate existing, planned and future
genome sequencing projects
Large genome project initiatives such as 1001 Arabidopsis
genomes (www.1001genomes.org), 1000 fungal genomes
(http://1000.fungalgenomes.org/home/), 10000 vertebrate ge-
nomes (https://genome10k.soe.ucsc.edu/) or 5000 arthropod
genomes (www.arthropodgenomes.org/wiki/i5K), to list only
a few, are probably the melting pots to incubate the future
neoENCODE programmes. Discussions in these commu-
nities are already tackling issues such as harmonization of
protocols and standards. This harmonization should pro-
bably be done through common portals and interfaces
allowing for future common annotations-types and formats.
A genome is never completely assembled or annotated. But
assembly and annotation efforts need to be maintained for
genomes entering the stage of functional annotations. This
foundational step establishing uniform genome quality is
already clearly needed, and much has been done to bring it
about [28].
Prioritize the systems
Obviously it is the duty of each concerned community
to elect the organisms they want to explore with func-
tional genomics technologies. The reasons beyond the
choice of model vary from case to case: mainly econom-
ical (agriculture, medicine, conservation…), or of evolu-
tionary importance (the first non-primate mammal, the
first cetacean, etc.…).
It will be essential for researchers working in new sys-
tems to ascertain good material production pipelines,
with the capacity to perform multiple biological repli-
cates, as well as organ, tissue, and cell-type dissections
and mass isolations (see below).
Choose the experimental conditions and targeted organs
and tissues
One of the aims of neoENCODE strategy is to focus on
defined, novel and ecological traits, not to re-analyze
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model organisms. The choice of particular targets for
organ or tissues dissections is thus essential for i) origin-
ality, ii) designing focused experiments, iii) limiting
costs, iv) eventually limiting the complexity of the tar-
gets in terms of cell type diversity that might complicate
expression data interpretation. Choosing the right organ-
isms and targets is essential also to reduce the risk of re-
dundancy between species. Cell lines do have technical
advantages (relative homogeneity, large quantity, more
amenable to RNAi, etc.) but also one significant disad-
vantage: they do not fully reproduce the phenotypes of
the tissues from which they are derived [29]. That is
why, in the scope of a neoENCODE project, a particular
emphasis should be placed on the choice of target organ
systems and temporal windows for each species. While
keeping the uniqueness of each species in mind, we also
need to choose tissues and/or developmental time-
points that will allow direct and interpretable compari-
sons between organisms.
Choose the common data-types to produce
One goal here is to cover many different steps in the hier-
archy of gene function and regulation. The first, basal layer
of data to produce is of course transcriptomics, including
coding and non-coding RNAs (mRNAs, rRNAs, tRNAs,
snoRNAs, miRNAs, siRNAs, piRNAs and equivalent, long
non-coding RNAs).
Beyond RNA content are the mechanisms of gene
regulation. Another aim of the ENCODE projects was
the annotation of regulatory elements. It has been shown
that general chromatin information captured by assays
such as FAIRE-, MAINE- and DNase-Seq [30,31] is indi-
cative of gene regulation function, and these assays have
been used to identify active promoters and enhancers.
Such experiments can be performed in priority and eas-
ily on most new-models. Still, these experiments require
a larger amount of biological material (up to 108 cells in
the case of DNase-seq) and more protocol optimization
than for simpler RNA extraction. A third type of experi-
ment is of course ChIP-seq, used to reveal regions
bound by regulatory or structural proteins. Of these we
distinguish Histones (and more particularly their post-
translational modifications) and Transcription Factors
(TFs). The difficulty is that there are hundreds of histone
modifications, with many new described all the time (e.g.
[32]). Animal genomes annotated so far encode between
one and three thousand transcription factors, and new spe-
cies, particularly those with large genomes, may encode
many more. This figure is currently out of reach for a
neoENCODE project. Pioneering work performed on
Drosophila melanogaster shows that chromatin marks can
be grouped into five different biological states [33]. Later,
modENCODE provided a 9-state and even a 30-statemodel [12,34] representative of different classes of DNA
Elements. Across organisms, the Histone modification
H3K4me3 seems generally to be a good marker for active
transcription start sites. Similarly, CTCF, in Mammals and
Drosophilids, seems to be the main insulator protein, even
though exceptions occur [35,36]. C. elegans, for example
doesn’t possess CTCF [37]. With this in mind, we propose
to select a small set of conserved TFs and Histone modifi-
cations to perform systematic ChIP analyses in all the se-
lected new models in order to annotate candidate regions
linked to gene repression or activation. One key difficulty
will be the availability of antibodies for new organisms.
Working with established industrial collaborators, will be
essential to enable high-throughput functional genomics in
new systems.
These studies can of course be complemented by analyz-
ing post-transcriptional regulation by RNA binding proteins
(RBPs). There are between half (humans [38]) and two third
(flies [39]) as many RBPs as TFs in most annotated animal
genomes. And of course, there are many other forms of
regulation as well (pre-post transcription…), e.g. DNA
methylation, chromosomes conformation and structural
regulation (the role of centromeres and telomeres for ex-
ample), or even transposable elements hopping. Other steps
of gene regulation can be investigated by polysome extrac-
tion and RNA sequencing to determine the pool of RNAs
that are under translation (associated with polysomes), but
this has proved difficult to transfer between species, due to
the need for extensive optimization [40].
Build the computational pipelines
Bioinformatics begins with a genome database: gene
expression data is best analyzed in reference to a gen-
ome annotation. This means that a dedicated database is
required. Usually, raw data are cleaned and mapped to a
reference genome. These steps are now pretty well-
defined and do not cause difficulties for trained scien-
tists. In all cases, the multiplicity of samples requires
access to substantial computational and storage capaci-
ties. Bioinformatic platforms and/or data centers are ne-
cessary for accomplishing these analyses. Of course, the
neoENCODE project needs the involvement of trained
computer scientists, and trained genomicists in analysts
and programmers. Systems such as Galaxy [28] allow bi-
ologists, after brief training, to handle large quantities of
data and perform some analyses. Hence, there exist ex-
cellent models for what we aim to accomplish. Again,
herein we do not pretend to propose a unified bioinfor-
matic platform: we think each neoENCODE community
will organize their computational infrastructure before
joining the project.
But the final critical step of a neoENCODE strategy will
be software development allowing data integration and
comparison through a wide range of species. Mathematical
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most researchers in molecular biology and ecology, and
neither is it for the authors of this tribune. Thus, col-
laboration with modelers is necessary, and, hence, it
will be important to work with individuals with mixed
biological, mathematical, and/or computational train-
ing, who can serve as conduits between the white-
board, the computing cluster, and the wet-bench. This
will require a dialog between different experts. And
this step can be also more feasible by beginning inte-
gration of a small number of objects (2 or 3 such as
mRNA, miRNA, TF) and to step by step enrich the
models adding new data (DNA methylation…).
Conclusions
Many choices will need to be made in order to initiate
neoENCODE initiatives at an international scale on the
ecological genomics new era. One of them is the interest
of industries in such initiatives. The direct consequences
of such neoENCODE or genomics data integration for
industry and economical activities are still difficult to
evaluate, but at least this can be included in most of the
societal challenges defined for instance in Europe by the
European Community: “Health, Demographic Change
and Wellbeing” for biomedical research, “Food security,
sustainable agriculture and forestry, marine and maritime
and inland water research and the bioeconomy” for agrono-
mical research, “Climate Action, Resource Efficiency and
Raw Materials” for environmental research are examples.
These societal challenges reflect the general mid- and
long-terms goals our societies need to reach, and probably
followed by economical actors and stake holders. Whether
such neoENCODE strategies will be i) useful for private
companies and/or ii) used in their R & D programmes will
be rapidly evaluated when funding will be tracked by
academic groups.
If we are to begin to dissect the interface between the
biology of cells, organisms, and environments, we sug-
gest that a federated collaboration model will yield a
cost-effective path forward. One limitation of the strategy
we propose will be the size of the scientific community with
expertise in individual organismal and ecological systems.
Hence, out-reach will be critical to our success, and we
hope that this tribune is the beginning of a vigorous dialog
that may culminate in the generation of several neoEN-
CODE white papers dedicated on given organisms and bio-
logical questions. If we begin early to rally our forces, we
may have the opportunity to kick off the era of ecological
genomics the right way: as a unified, cost-effective commu-
nity with efficient communication and global data-quality
and analysis standards. In the very next future, one can ex-
pect that discussion on this tribune will fuel the progress of
neoENCODE strategies, and we encourage readers to
organize local or international workshops to explore thesenew possibilities and disseminate them in our community
of structural, functional, evolutional and ecological genomi-
cists. As well, common journals or group of journals (such
as BioMed Central) might also be used to strengthen to
connections between neoENCODE initiatives.
Reviewers’ comments
We thank the reviewers for their comments on an earlier
version of this Correspondence article.
Reviewer 1 (name withheld)
This opinion article is clearly intended to initiate a
conversation within the biological community regard-
ing the contribution of advances in genomic science to
our understanding of biological systems beyond trad-
itional model organisms.
The authors first emphasize the value of the ENCODE
and mod-ENCODE projects which have assembled an
impressive catalogue of genomic features, molecular in-
teractions, etc., outlining the critical service these pro-
jects have provided to the human and model organism
community. They also argue that the handful of trad-
itional model organisms currently available only allow us
to address a narrow set of biological problems. They
raise the question of whether or not Encode-like projects
should be democratized to a wider range of so-called
non-model organisms arguing for a resounding “yes”.
Their argument centers on the idea that our recent un-
derstanding of bio-complexity has changed how we
should study biological problems. The very knowledge
that was gained through the (mod)-ENCODE projects
and the complexity we have uncovered should motivate
similar studies following the same framework that would
allow the integration of data across various levels of bio-
logical organization.
Unfortunately, I am not convinced the authors have
clearly articulated what the goals and outcome of vari-
ous non-mod-ENCODE initiatives would be, especially
given the limitations outlined at the end of the article. I
realize that space is limited, and that this is not a white
paper, but outlining even briefly (with an example maybe)
how they envision such a project would materialize (not fi-
nancially but practically) would be tremendously helpful in
convincing the reader. If my organism of interest were for
example, a scale insect, what would a non-mod-ENCODE
initiative look like? What data would be collected, how and
what kind of biological questions such a complex catalogue
would serve to address. How many non-model organisms
should this be done for? How should they be selected?
Since there are so many potential non-model organisms,
these are relevant and complicated questions that should
be addressed, especially when the relative value of the effort
is very difficult to appreciate ahead of time. It would seem
given the limited resources we have to work with that we
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organisms rather than really expanding into (many) non-
model organisms. I suppose if resources were unlimited
then, non-modENCODE (I’d prefer beyond-modENCODE)
would be great, but resources are never unlimited. And
since high throughput next-gen tools are available to any
lab, scientists studying non-model organisms have plenty of
tools at their disposal to start to study adaptive evolution
(for example) without a huge community effort like (non)
modENCODE.
My concern however is with this statement that seems
to serve as the key rational for such projects: “Technic-
ally, working with non-model organisms means there is
no access to high throughput functional assays. Thus,
the most effective approach for deciphering the complex
adaptive biological mechanisms of non-model organism
is an ENCODE-like strategy”. First, I should emphasize
that it is still unclear what the mod-ENCODE projects
have accomplished toward this goal in model organisms
(and if it is clear to the author I urge them to explain
how). We still have a very long way to go to interpret
mod-ENCODE data in that context. Most of the data
collected to date, for example, do not even consider
the contribution of genetic variation or genotype-by-
environmental interactions, which could not be ig-
nored for non-model organisms. It would appear that
what the authors are arguing for is not a non-mod-
ENCODE project (and all that it entails – need for
controlled environmental conditions, assay of develop-
mental stages, in different tissues, etc.…). Instead they
advocate the development of genomic resources that
would enable the application of system-biology and
system-genetics to investigate complex biological problems
that are specific to certain groups of organisms. I do under-
stand the appeal of following in the footsteps of a successful
initiative, but this paper would be much improved if realis-
tic and more specific goals were outlined clearly. The an-
swer to the questions posed in the introduction [“what is
the point of a catalog of molecules without demonstration
of their functional roles? Is it worth getting such an amount
of purely descriptive data from non-model organisms
without having access to functional assays such as forward
genetics or transgenesis? Is it worth investing in the accu-
mulation of terabytes of data from non-model organisms?”]
can be answered with a simple “yes” because biology is
complex and genes do not act in isolation but as genetic
networks.
Advances in genomic technologies have without a
doubt changed many fields in biology, and the holy grail
of understanding the genotype to phenotype map in
functional terms within the context of the organism has
never seemed so close. As stated in this article, there is
much to be gained by bringing together disciplines that
have traditionally been isolated. Many of these new toolsthat are not available have given us a false sense of
confidence with respect to what we actually understand.
This trend probably started with the popularization of
microarrays, when a list of differentially expressed genes
became synonymous with genetic architecture and to
many redefined causality in biological experiments. I
think if the authors are to convince a large community
that considerable resources should be dedicated to cata-
loguing in great detail the genome of non-model organ-
isms (an endeavor I would personally gladly support),
the grand vision outlined in this paper would be much




School of Biological Sciences, The University of
Edinburgh
This is an interesting opinion piece that suggests ‘upscal-
ing’ our genomics approaches on non-model organisms,
and building ENCODE-like programmes to deliver ‘systems
biology’ level understanding of a wider range of organisms
than those currently studied.
The point of models is that they are taken to represent
the core biology of all species in a particular realm: so
we can have model species that model humans, or that
model development in a particular group, or that model
genetic processes.
It is perhaps necessary to revisit the model when a
phenotype of interest is not represented in the core set,
but analysis of these phenotypes can be achieved in new
or satellite models that do have the relevant biology.
The thesis is intriguing, but is poorly focussed, and
perhaps oversells the knowledge that can be mined from
the ENCODE data systems. I am not impressed by the
bite or reach of the arguments made, and the simplistic
call for ENCODE-like programmes on other organisms
could conflict with exploitation of the true utility of
these as systems in which population genetics can de-
liver real answers to questions of pattern and process in
the natural world.
Some comments:
(a) What has ENCODE actually done?
ENCODE has analysed the genome wide distribution
of epigenetic marks, chromatin states and of transcription
factor binding sites in humans, D. melanogaster and C.
elegans. Similar programmes are effectively underway for
key bacterial and fungal species (but here the ease of cul-
ture, single-celled target and size of the genome means that
the programmes are not vast in extent). Yes, the majority of
the human genome was ‘tagged’ by one or many different
analyses, but the claim that this means a “biochemical
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is a little overblown. In a large proportion of cases the mark
that has been identified is one that results in silencing and
transcriptional inactivity: so the “function” is to be devoid
of positive function. Secondly, the ENCODE analyses are
built on deep layers of previous functional genomics work,
and are in essence a series of correlations: the following epi-
genetic marks correlate with such and such other features
of the genome. By performing these analyses across many
cell lines of different phenotypes the ENCODE teams were
able to infer the logical structures of many of the core regu-
latory systems in the human, and to identify where likely
disease-causing variations were likely to occur, and provide
frameworks on which to build models of disease (and
health) causation.
In doing these analyses ENCODE has built new suites
of analytic tools and approaches to huge data that are
likely to be of general applicability.
(b) what are the target non-model organisms?
It is unclear what the non-model organism set being
proposed is. There are ~10 million animal species on
earth; 1 million have Linnaean names. There are, in
addition many, many million more plants, fungi, various
phyla of protozoa/protoctista, bacteria, archaea and the
soup that is the viral world. Of these millions, perhaps
10,000 are seriously studied at the genomic level. Many
of these studied species are already proposed as satellite
or new model organisms, specifically to model pieces of
phenotype space that the core models cannot. It is very
likely that encode-like programmes could be carried out
on this much-restricted non-core model set, as long
as the need to understand the system in detail meshes
with the accessibility of the organism/phenotypes be-
ing studied.
(c) is an ENCODE approach technically possible?
Given good reference genome sequence data, many of
the core analyses performed in ENCODE could be re-
peated on any organism - looking for DNA methylation
marks using custom antibodies or chemical modification
to separate the Me marks from the unmarked DNA,
looking for open chromatin using DNAse1, or fully
cross-reactive anti-modified histone antibodies to
identify histone marks. However much of the specific
data generated in ENCODE used pecific immunopre-
cipitation using antibodies generated against a series of
transcription factors. These reagents are not simply
transferrable across species (and indeed much of the
work leading up to ENCODE was proving the exquisite
specificity of these reagents). Developing these anew is
not trivial.ENCODE (and, to some extent, Drosophila modEN-
CODE, but not C. Elegans modENCODE) relied on cell
lines - clonal growths of isolates with a stable phenotype.
Cell lines are not available for most taxa (there are none
for C. elegans, for example) and generating cell lines is
not trivial (C. elegans is a case in point -the lack of cell
lines is not for want of trying). modENCODE relied
much more on tissue and whole organism samples, and
this is likely to be true of any “nonmod” programmes
also. This inability to move to the cellular level will limit
the systems biology that can be done.
That said, many “new-model” organisms are effectively
being “encoded” – the honeybee, many farm animals
and agricultural crops, some satellite models of the key
species… all have extensive programmes of systems re-
search underway.
(d) an elephant in the room
I was surprised at the emphasis on adaptive evolution
in the text. It is clear that the shape of any genome, and
the phenotype of any organism, is the outcome of both
selection and neutral processes (including hitchhiking,
bottlenecks, etc.). To suggest that the structure of the
systems biology models that emerge from ENCODE re-
veal adaptation only is overly Panglossian: much of the
structure must arise from stochastic fixation and drift.
The null hypothesis in any analytic experiment that is
looking at evolutionary change must be that the pattern
observed is due to neutral processes.
(e) what are non-model/new-model organism researchers
doing?
Looking across the new model organisms, and across
the wider field of the use of organisms that are not the
core models, several things are evident. The first is
that the questions being asked and answered may not
NEED genomics or functional genomics data to be ac-
curate and informative. The second is that in many
cases the approach taken is that of population genetics:
identifying variation of interest within or between
species, and then using whole organism genetics to
identify the proportion of the variation that is genetic,
and then using quantitative trait or association genet-
ics to identify the genetic structure of the trait, and the
dynamics of trait evolution. It may be of interest then
to go to the genomic level, and to identify quantitative
trait nucleotides, and investigate the biological mecha-
nisms (at the levels of transcription, translation, pro-
tein function, cell phenotypes, tissue organisation/cell
communication and organismal physiology) that under-
pin the variation observed. On the other hand it may
not.
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The language of the article needs some cleaning, and
there are several sentences where I was unable to work
out what was meant.
– “ a DNA element functional in its wider acceptation”
– “description of biodiversity at a molecular level”
– “clearly modified or clarified the notion”
In addition there were several claims of fact or gener-
alisations that were not supported by reference and seem
to me to be dubious:
– “mice are not adapted to spontaneous disease”
– “adaptive evolution … often implies the mobilisation
of transposable elements”
– “added values in non-models … is access to natural
populations” (surely the history of work on humans
and Drosophila is significantly driven by natural
population work?)
There are some trivial statements:




Centre for Genomic Regulation (CRG), Barcelona
The proposal for a non-mod-ENCODE, that is, for
ENCODE like initiatives for non model organisms is
very timely. Therefore I fully support the message in the
manuscript. On the wave of the recent publication of the
ENCODE manuscripts and of the upcoming publication
of the comparative ENCODE modENCODE results, the
publication of the manuscript is particularly appropriate.
I believe that I mostly agree with the main reason for
non-mod-ENCODE projects: “We have no choice”. Ob-
viously, I would have written a different paper, empha-
sizing different topics. Thus, my differences with the
manuscript are mostly of style rather than content.
There are a couple of areas, in which the authors
could make additional emphasis. Please, take these just
as suggestions:
First. Very few people today still hold the position that
genome sequencing (of novel species) is a waste of
resources. However, to fully mine a genome sequence,
we need to have information about its function/activity.
Recent advances in Next Generation Sequencing makes
affordable overlaying transcriptomic and epigenomic
information onto a given genome sequence in a diverse
panel of cell types, and conditions.Second. The authors cite as a limitation in non model
organisms, the lack of high throughput functional
assays. This is actually a strong motivation for
ENCODE like projects. It is not only a cost-effective
way to understand genome function on these organ-
isms, it is the only way.
Third. One of the main outcomes of the ENCODE and
modENCODE, beyond the biological insights that they
have produced, is the delineation of standards and
recommended practices, both regarding experimental
and computational procedures. In fact, a large part of
the ENCODE effort has been likely devoted to this.
This has been extremely beneficial for the community,
and in particular for any nonmod-ENCODE project.
The authors allude to this, when they mention epigen-
etic markers already used in ENCODE, but they could
go beyond this and include many other features of the
experimental and computational pipelines (for instance,
the use of replicates and of statistical methods to focus
analysis on reproducible data, the QC metrics, or the
recommended computational protocols for mapping,
ChIPSeq and RNASeq analysis. The availability of these
standards and recommended protocols is what makes
non-mod-ENCODE projects possible.
Fourth. It is impossible to understand a genome in
isolation. Life is a continuous. And as powerful as
comparative genomics has been to understand the
human genome itself, and the genomes of important
medical and socio-economic value to humans,
comparative transcriptomics and epigenomics—that
non-mod-ENCODE projects would make possible—will
be to understand the functioning of these genomes of
such direct practical importance to us. I think this is also a
strong argument for non-mod-ENCODE projects Fifth.
The ENCODE and modENCODE projects are largely
cooperative projects involving hundreds of scientists
working in distant parts of the globe. This is creating
a new culture of cooperation and sharing that could
be very positive for smaller communities.
A few additional minor comments:
1. page 1.“… provides the opportunity to heavily an
even exhaustively describe the availability of
different DNA-associated epigenetic and chromatin
states”. “describe the availability” sound odd to me
2. The authors bring Biomathematics as providing
gene networks allowing biologist to integrate the
data. However, simpler models, for instance,
predicting gene expression from histone
modification data are already very useful.
Reviewer 4
James Ben Brown
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This correspondence piece attempts to establish and
initiate a dialog surrounding a putative new international
initiative in ecological genomics. This is a very important
and worthwhile thing to attempt.
However, the paper is not yet of publishable quality:
the language needs serious work, and there are a num-
ber of errors and misconceptions regarding functional
genomics. Also, the authors make it sound like the
ENCODE and modENCODE consortia have been the
only motive force in functional genomics for decades,
which is far from true.
Because I am extremely keen on the topic the authors
have elected to champion, I have made edits in Word, in
track-changes, something I have never before taken the
time to do as a reviewer. Please find attached a detailed
review, in track-changes, with comments throughout. I
hope that this will be of help to the authors, and will aid
them in their very, very worthy quest.
Reviewer 5
Brian Oliver
The National Institutes of Health (NIH)
Proposing a more complete annotation of additional
genomes is an interesting idea and well worth a public
debate. Collectively, the authors have experience in both
“non-genetic” model systems and in high throughput an-
notation projects and as such are a good team for voi-
cing an opinion.
I think that they could make some points more dir-
ectly and I have a few suggestions for them to consider,
but it is their paper and opinion, so I do not think it is
really appropriate to make any of these mandatory.
They are just suggestions and observation for them to
consider.
1) The significance section is the most important part
of the document, so it should probably be several
pages long. As it stands, there are three poorly
developed concepts that are all good, but all tersely
presented and vaguely documented. This makes the
first part of the piece quite muddy and less likely to
convince skeptics.
One main rational seems to be based on the idea that
for any biological problem there is an ideal model organ-
ism. This is an old and successful theme that went out
of fashion during the early days of molecular genetics
due to the lack of resources, particularly mutations, and
then later on, assembled genomes. It is coming back,
and the authors could clearly outline the history of the
concept, state why it is coming back, and how an
ENCODE project would help. Another point mentions
health, Ag, and environmental needs with absolutely nojustification. I imagine that the authors see large num-
bers of users in industry and research here, but they do
not make any statements about how big these industrial
communities might be. They should really link the pro-
posal to defined areas of existing interest in things like
REACH or Tox21. Various Ag companies spend a lot of
money (how much?) doing extensive genotyping and I
would guess that the productivity of this enterprise
would skyrocket with an appropriate reference annota-
tions for wheat, maize, rapeseed, etc.… These are both
important, and each should be more fully developed.
Finally, the authors raise the important point that an as-
sembled genome is not very useful without an annota-
tion. Here I think I would discuss some of the universal
annotation engines that are under development (e.g.
gnomon) and how they make use of biological evidence
such as RNA-Seq to build annotations. Again, the
neoENCODE project could help those packages work
more effectively for minimal amounts of money. The
list of questions at the end of the section weaken the
argument and don’t contribute to the point the authors
are making.
Let detractors write their own critiques.
2) I think it is a mistake to propose a project without
some more information on how many species to
tackle and maybe this idea should be planted early in
the manuscript, rather than waiting until page 5 (the
roadmap section itself is very strong). If the idea is
to cover a lot of phylogenetic space, I would justify
the density of neoENCODE work based on factors
such as scientific activity (pubMed search results),
quality of existing genomes, number of extant
species in the group, economic importance, etc.…
The goals need development, and I think that the
authors first goal is to identify the important
stakeholders and propose a meeting to discuss the
issue. This is exactly what happened to launch
ENCODE and modENCODE (there were multiple
meetings and workshops for about 5 years before
the first call for proposal went out at the NIH and
I’m sure that similar levels of ground work would be
required in the EU or at other granting agencies. If
industry is the source, they will require similar due
diligence).
3) Natural population data is important, but model
organisms also exist in nature, so this particular
argument is logical fallacy. That the communities in
question have more expertise and interest in natural
populations is a much better argument.
4) If communities elect organisms and specific systems,
it is not hard to predict what they will vote for. If a
reference project gets too tied into the biological
interests of the investigators, then the project will
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project. It cannot be just a way for certain labs in
“the club” to get funding.
5) I think the lists of types of data that could be
generated are too long. Since they really flow
directly from ENCODE and ModENCODE, the
authors could just have a text box or table. From a
practical point of view, I would emphasize the cost/
benefit analysis (e.g. tagged transcription factors
versus genome-wide footprinting) as learned by the
previous projects. Given that the lead time for
launching such an initiative could be long, I would
also discuss what may be technically possible in five
years in addition to what we can do today.
6) I’m not completely clear on what the authors would
like readers to do. Are they inviting comments?
Published discussion? I still think that the authors
should use this manuscript to propose a workshop.
Reviewer 6
James H. Marden
Department of Biology, Penn State University
I have now read both the initial reviews and what ap-
pears to be the revision of this manuscript. I was not
among the initial reviewers.
First let me state that I do not know very much about
the ENCODE Project and I don’t have time to invest in
learning about its particulars at this time. I do know that
aspects of the set of Sept 2012 Nature publications and
the way the press reported the findings have been
sharply criticized. I have read two of those critiques
(Dolittle, Graur), both of which focus much attention on
estimates of the fraction of non-coding DNA that is
functional. The Dolittle critique is measured and reason-
able; the Graur critique is more detailed and, points out
a number of the pitfalls of BIG SCIENCE (inconsistent
definitions, methods, and database procedures). Both
critiques point out the glaring absence and need for evo-
lutionary analyses in ENCODE studies. The present
manuscript contains a single sentence acknowledging
only the existence of these criticisms; it doesn’t grapple
with them but rather charges forth to a “Let’s do it!”
rallying cry at the end.
There are a number of things about this perspective
that don’t sit well with me.
First, I am a typical maverick scientist; I run a small
lab and prefer to pose my own questions and design my
own approaches. I don’t like to be told what to do and
my default state is to distrust and question calls for top-
down approaches to scientific endeavors. I’m certainly
not alone in having such a nature. Consider for example
how Craig Venter found his own way to obtain a human
genome sequence while working outside the BIG SCI-
ENCE approach of the Human Genome Project. Venterwould not want other people telling him that his work
should be organized around a group determined re-
search design, and neither would I.
Second, the viewpoint presented here seems quite un-
realistic about the objectives of research on non-model
organisms, the best of which utilizes extensive data and
analyses (e.g. a rich phylogenetic context; time series and
or other dynamics data from nature; spatially explicit
population data; responses to ecological variation; well
established evolutionary genetics using rigorous statistics
and a null hypothesis of neutrality) in order to ask inter-
esting questions about a particular species and to gain
some possibly general insights. It is only the worst gen-
omic approaches with non-model species that aim only
to obtain a large amount of sequence data without a
compelling reason to do so and with little knowledge of
what to do with the data. Much of the latter does get
published (including in this journal) but that in no way
motivates my thinking about the best ways to approach
new research.
That said, there is clearly great importance in building
and maintaining public databases of sequence data and
associated functional annotation, but this paper is not
about databases per se. Gaining insights about the gen-
etic mechanisms underlying interesting features of a par-
ticular species is often (but not always) a goal of the best
genomic research in non-model species. Clearly there
will be cases where non-coding regulatory elements are
key parts of the answer, but for the vast majority of non-
model species research, there will not be a big enough
team to undertake an Encode-style approach. Despite such
limitations (which the authors acknowledge), they present a
perspective that proclaims, metaphorically, that because
gold-plated plumbing can now be made and is superior, all
subjects in the kingdom should pool their resources and
begin installing gold plate on all faucets.
Perhaps most importantly, this perspective does not
begin by asking “What is the best way to make new dis-
coveries of importance in non-model species?”. If they
asked that question first, and carefully built an argument
that the best approach in most cases will be a genome-
wide, multi-level informatics approach using a wide
array of functional interrogation, then I could respect
the paper even if I disagreed with it.
Rather, they seem to assume this as a starting position,
but nonetheless conclude that “.... we view these mech-
anisms as specifically linked to particular biological
questions and thus need only be generated on a case-
by-case basis.” If the detailed genome-wide molecular
mechanisms are not of general interest, but rather
there is a subset of interesting mechanisms linked to
particular biological questions (a position with which I
agree wholeheartedly!), then what is the best scientific
approach? Would the best targeted approach look like
Tagu et al. BMC Genomics 2014, 15:490 Page 14 of 16
http://www.biomedcentral.com/1471-2164/15/490ENCODE (i.e. interrogate the entire genome for all sig-
nals of content, structure and function)? The much
better paper would ask and answer 1) what are the
positive and negative lessons that non-model species
biology can learn from ENCODE, and 2) can, and if so
how, do we best apply such approaches in small teams
with limited resources interrogating specific biological
questions in non-model species?
Major compulsory revisions:
1. Be more concrete early in the paper about what the
ENCODE project produced using methods that are
transportable to non-model species research at
particular levels of scale (e.g. 10 labs, 5 labs, 1 lab).
2. Devote at least a paragraph to the critiques of
Dolittle and Gruar. These are important,
substantive, and need to be discussed for your
perspective to have broad credibility.
3. Early on in the paper, discuss what you think is the
best scientific approach for using ENCODE inspired
methods on species with restricted biological and
financial resources. Provide an example. For
instance, perhaps you know of a species in which a
trait of interest maps to a particular chromosomal
region. Can that region be examined using
ENCODE-like approaches, and if so, what are the
likely benefits? Do some teaching here because
non-model types don’t yet know much about
ENCODE and what it has produced.
4. Strive for realism throughout. Be pragmatic. How
can we take the first small steps and make
incremental progress?
5. Have a native English speaker go over the writing.




University of California Berkeley
This is a short opinion piece meant to increase aware-
ness of the importance of ENCODE-like projects for
non-model organisms. I am already convinced of the im-
portance of this, myself, so it was mostly just reinforcing
my own views, but there are others in the community in
greater need of convincing. I recommend acceptance




Page 1, paragraph 2: “nocturnalcontrary” should read
“nocturnal, contrary”
Page 2, line 1, is missing a comma after “transcrip-
tomic” and, if you follow the Oxford method, after
“proteomic.”Page 2, line 4: “trend does not seem to stop any time
soon” should read “trend does not seem likely to stop
any time soon”
“Biomathematics” is inconsistently hyphenated.
Page 7, lines 2 and 7: “Histones” is inappropriately
capitalized.
Page 7, line 13: “through” is misspelled. Add a comma
after “. . . a genome)”
Page 7, line 16: Add a comma after “telomeres”.
At three points in the ms., the word “tribune” is used
inappropriately.
In the Authors’ Contributions, they state, “DT was at
the initiative of this brainstorming” when I think what is
meant is “DT initiated this brainstorming”. In addition, I
view the word “brainstorming” here as inappropriately
colloquial and not really very accurate.
Discretionary Revisions
Page 1, paragraph 2: It seems odd to point out short-
comings for specific subsets of these model organisms
that apply to all or most of them just as well. I suggest
rewriting this to state the aspects of life that are not
addressed by studies of these model organisms and ex-
plain why this is important to do so. I question whether
“Biomathematics” is a very accurate description of what
the authors intend.
I question, too, whether “neoENCODE” is a very accurate
description of that the authors intend. Are these organisms
really in a category of “newness” relative to the organisms
targeted by ENCODE and modENCODE?.
The authors state, “working with non-model organisms
means there is no access to high throughput functional
assays.” This seems overstated to me, both because there
are some high throughput functional assays that are avail-
able for some non-model organisms and because of the im-
plication that such assays are readily available for model
organisms, which is not always the case. An additional
point that could be emphasized is the problem of “percola-
tion of errors” stemming from the use of one genome to
annotate the next, on and on, like a game of “telephone.”
There may be great value in regularly revisiting assignments
of paralogy and orthology as greater numbers of genomes
and greater accuracy of gene modeling become available.
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